Sponsored By

Novel plant-based omega-3 delivers improved blood profiles – white paper

Download this white paper to learn more about Nutriterra® Total Omega-3 Canola Oil, a novel plant-based source of total omega-3 that, in a human clinical trial, significantly improved blood profiles.

March 1, 2021

1 Min Read
Novel plant-based omega-3 delivers improved blood profiles – white paper

Nuseed® is a land-based source of omega-3 fatty acids (ω3FA), containing significant amounts of DHA and ALA. Nutriterra® provides the first non-marine source of long-chain ω3FA to help meet dietary requirements and the growing consumer product demand for these fatty acids, while reducing the environmental impact of extensive fishing of oily fish, the major source of long-chain ω3FA. Nuseed and its partners recognized an opportunity to sustainably meet the increasing omega-3 demand, while preserving marine resources.

Omega-3 fatty acids have been the subject of extensive research, with beneficial effects reported in numerous studies. This white paper presents detailed scientific information on the importance of ω3FA and the omega-6 fatty acid (ω6FA) to ω3FA ratio to human health, the shortfall between intake and recommendations, and the need for a sustainable supply. Additionally, it summarizes the research undertaken by Nuseed and its partners to create the ω3 canola oil and confirms the safety and efficacy of this novel oil, as well as the regulatory and marketing aspects of Nuseed’s unique total ω3 oil, Nutriterra.

Read on to learn more about this important sustainable plant-based solution for improved omega-3 blood profiles, and the opportunity for your product formulations for today's sustainability-minded consumer.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like